archive-fr.com » FR » I » IT-INITIATIVE.FR

Total: 133

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Criteria
    Press release Contact Plan You are here Home News inserm Criteria News Press release Partners News Page à supprimer магазин DVD фильмов Battlefield 4 Beta обзоры тесты новости Home About us Our history Investors Partners Investment Investment Strategy Investment Process

    Original URL path: http://www.it-initiative.fr/news/78-inserm/82-criteria (2015-10-11)
    Open archived version from archive


  • News
    in the pharmaceutical industry Dr Garaud has been recently Head of Pharma Research and Early Development at Roche from 2010 to 2012 and Head of Development and Chief Medical Officer at Roche from 2007 to 2010 He previously held other senior positions with Schering Plough in the USA from 1991 to 2001 and with Novartis in the USA and Switzerland from 2001 to 2007 He is a board member of Chugai Pharmaceuticals in Japan Text to come Axilum Robotics Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS website Bioaxial Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Bioaxial breakthrough technology enables enhanced imaging capabilities required for advanced research Bioaxial offers a range of improved imaging solutions integrated to confocal microscopes platforms This flexible offering enables the user to easily upgrade existing confocal microscopes for improved resolution website DNA Therapeutics Novel approach using DNA fragments siDNA mimicking DNA damage By jamming DNA damage sensing and signaling siDNA can increase the efficacy of radiotherapy and chemotherapy without adding any cytotoxic effect The lead compound DT01 is currently in phase I IIa in melanoma website Effimune Discovery and the development of novel immunomodulators and more specifically modulatory drugs for the co stimulation of T cells The lead antibody FR104 is a CD28 antagonist under regulatory preclinical development showing promising proof of concept in the protection of graft rejections website Eyevensys Novel solutions for sustainable intraocular production of therapeutic proteins website Genoscreen Services related to detection and characterization of genetic variants sequencing and genotyping SNPs microsatellites website Hemarina Development of a haemoglobin oxygen carrier extracted and purified from a marine organism

    Original URL path: http://www.it-initiative.fr/news/78-inserm?style=green&start=10 (2015-10-11)
    Open archived version from archive

  • News
    in the pharmaceutical industry Dr Garaud has been recently Head of Pharma Research and Early Development at Roche from 2010 to 2012 and Head of Development and Chief Medical Officer at Roche from 2007 to 2010 He previously held other senior positions with Schering Plough in the USA from 1991 to 2001 and with Novartis in the USA and Switzerland from 2001 to 2007 He is a board member of Chugai Pharmaceuticals in Japan Text to come Axilum Robotics Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS website Bioaxial Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Bioaxial breakthrough technology enables enhanced imaging capabilities required for advanced research Bioaxial offers a range of improved imaging solutions integrated to confocal microscopes platforms This flexible offering enables the user to easily upgrade existing confocal microscopes for improved resolution website DNA Therapeutics Novel approach using DNA fragments siDNA mimicking DNA damage By jamming DNA damage sensing and signaling siDNA can increase the efficacy of radiotherapy and chemotherapy without adding any cytotoxic effect The lead compound DT01 is currently in phase I IIa in melanoma website Effimune Discovery and the development of novel immunomodulators and more specifically modulatory drugs for the co stimulation of T cells The lead antibody FR104 is a CD28 antagonist under regulatory preclinical development showing promising proof of concept in the protection of graft rejections website Eyevensys Novel solutions for sustainable intraocular production of therapeutic proteins website Genoscreen Services related to detection and characterization of genetic variants sequencing and genotyping SNPs microsatellites website Hemarina Development of a haemoglobin oxygen carrier extracted and purified from a marine organism

    Original URL path: http://www.it-initiative.fr/news/78-inserm?style=red&start=10 (2015-10-11)
    Open archived version from archive

  • News
    in the pharmaceutical industry Dr Garaud has been recently Head of Pharma Research and Early Development at Roche from 2010 to 2012 and Head of Development and Chief Medical Officer at Roche from 2007 to 2010 He previously held other senior positions with Schering Plough in the USA from 1991 to 2001 and with Novartis in the USA and Switzerland from 2001 to 2007 He is a board member of Chugai Pharmaceuticals in Japan Text to come Axilum Robotics Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS website Bioaxial Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Bioaxial breakthrough technology enables enhanced imaging capabilities required for advanced research Bioaxial offers a range of improved imaging solutions integrated to confocal microscopes platforms This flexible offering enables the user to easily upgrade existing confocal microscopes for improved resolution website DNA Therapeutics Novel approach using DNA fragments siDNA mimicking DNA damage By jamming DNA damage sensing and signaling siDNA can increase the efficacy of radiotherapy and chemotherapy without adding any cytotoxic effect The lead compound DT01 is currently in phase I IIa in melanoma website Effimune Discovery and the development of novel immunomodulators and more specifically modulatory drugs for the co stimulation of T cells The lead antibody FR104 is a CD28 antagonist under regulatory preclinical development showing promising proof of concept in the protection of graft rejections website Eyevensys Novel solutions for sustainable intraocular production of therapeutic proteins website Genoscreen Services related to detection and characterization of genetic variants sequencing and genotyping SNPs microsatellites website Hemarina Development of a haemoglobin oxygen carrier extracted and purified from a marine organism

    Original URL path: http://www.it-initiative.fr/news/78-inserm?style=orange&start=10 (2015-10-11)
    Open archived version from archive

  • News
    in the pharmaceutical industry Dr Garaud has been recently Head of Pharma Research and Early Development at Roche from 2010 to 2012 and Head of Development and Chief Medical Officer at Roche from 2007 to 2010 He previously held other senior positions with Schering Plough in the USA from 1991 to 2001 and with Novartis in the USA and Switzerland from 2001 to 2007 He is a board member of Chugai Pharmaceuticals in Japan Text to come Axilum Robotics Novel robotized solutions to assist Health Care Professionals with medical procedures The first product is a robot to assist psychiatrists and neurologists in delivering Transcranial Magnetic Stimulation TMS website Bioaxial Bioaxial is developing and providing high resolution imaging instruments for the worldwide R D teams of the Life Sciences and Healthcare Bioaxial breakthrough technology enables enhanced imaging capabilities required for advanced research Bioaxial offers a range of improved imaging solutions integrated to confocal microscopes platforms This flexible offering enables the user to easily upgrade existing confocal microscopes for improved resolution website DNA Therapeutics Novel approach using DNA fragments siDNA mimicking DNA damage By jamming DNA damage sensing and signaling siDNA can increase the efficacy of radiotherapy and chemotherapy without adding any cytotoxic effect The lead compound DT01 is currently in phase I IIa in melanoma website Effimune Discovery and the development of novel immunomodulators and more specifically modulatory drugs for the co stimulation of T cells The lead antibody FR104 is a CD28 antagonist under regulatory preclinical development showing promising proof of concept in the protection of graft rejections website Eyevensys Novel solutions for sustainable intraocular production of therapeutic proteins website Genoscreen Services related to detection and characterization of genetic variants sequencing and genotyping SNPs microsatellites website Hemarina Development of a haemoglobin oxygen carrier extracted and purified from a marine organism

    Original URL path: http://www.it-initiative.fr/news/78-inserm?style=blue&start=10 (2015-10-11)
    Open archived version from archive

  • Criteria
    Press release Contact Plan You are here Home News inserm Criteria News Press release Partners News Page à supprimer магазин DVD фильмов Battlefield 4 Beta обзоры тесты новости Home About us Our history Investors Partners Investment Investment Strategy Investment Process

    Original URL path: http://www.it-initiative.fr/news/78-inserm/82-criteria?style=green (2015-10-11)
    Open archived version from archive

  • Criteria
    Press release Contact Plan You are here Home News inserm Criteria News Press release Partners News Page à supprimer магазин DVD фильмов Battlefield 4 Beta обзоры тесты новости Home About us Our history Investors Partners Investment Investment Strategy Investment Process

    Original URL path: http://www.it-initiative.fr/news/78-inserm/82-criteria?style=red (2015-10-11)
    Open archived version from archive

  • Criteria
    Press release Contact Plan You are here Home News inserm Criteria News Press release Partners News Page à supprimer магазин DVD фильмов Battlefield 4 Beta обзоры тесты новости Home About us Our history Investors Partners Investment Investment Strategy Investment Process

    Original URL path: http://www.it-initiative.fr/news/78-inserm/82-criteria?style=orange (2015-10-11)
    Open archived version from archive